Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2650 of 3546 entries
View as:

Efficacy of Potassium Nitrate Solution in Reducing Dentinal Hypersensitivity

Phase: N/A Priority: Normal
NCT ID: NCT01115452 Org: User:
Start: 09/30/09 End: 10/31/09 Due: 10/31/10

Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT00402363 Org: User:
Start: 11/30/06 End: 01/31/10 Due: 01/31/11

Clinical Study to Evaluate Efficacy of New Paracetamol Formulation Compared to Ibuprofen in Headache

Phase: N/A Priority: Normal
NCT ID: NCT01842633 Org: User:
Start: 04/01/13 End: 03/31/15 Due: 03/31/16

Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune Response

Phase: N/A Priority: Normal
NCT ID: NCT00197158 Org: User:
Start: 03/31/05 End: 12/31/05 Due: 12/31/06

A Study to Assess the Pharmacologic Equivalence of Two Orlistat Dosage Forms

Phase: N/A Priority: Normal
NCT ID: NCT01550926 Org: User:
Start: 02/28/09 End: 03/31/09 Due: 03/31/10

Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT01905215 Org: User:
Start: 07/22/13 End: 03/16/15 Due: 03/16/16

Dose-Optimization, Adjunctive Treatment Study of Ezogabine/Retigabine Immediate Release in Partial-onset Seizures

Phase: N/A Priority: Normal
NCT ID: NCT01721317 Org: User:
Start: 12/19/12 End: 06/20/13 Due: 06/20/14

Clinical Trial of Safety, Tolerability and Antitumor Activity of Genetically Engineered T Cells in Combination With Anti-Cancer Agents in Relapsed and Refractory Synovial Sarcoma Expressing New York Esophageal Antigen-1 (NY-ESO-1) and/or LAGE-1a

Phase: N/A Priority: Normal
NCT ID: NCT03697824 Org: User:
Start: 02/25/19 End: 07/18/22 Due: 07/18/23

Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00090103 Org: User:
Start: 11/30/03 End: 04/30/09 Due: 04/30/10

Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared

Phase: N/A Priority: Normal
NCT ID: NCT00197184 Org: User:
Start: 11/01/03 End: 03/10/04 Due: 03/10/05

Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814

Phase: N/A Priority: Normal
NCT ID: NCT00403585 Org: User:
Start: 07/31/06 End: 04/30/08 Due: 04/30/09

A Study of GSK3228836 in Participants With Chronic Hepatitis B (CHB)

Phase: N/A Priority: Normal
NCT ID: NCT04449029 Org: User:
Start: 07/27/20 End: 03/18/22 Due: 03/18/23

Investigation Of Weight Loss And Body Composition Changes After Dosing With Either Placebo Or One Of Two Active Drugs

Phase: N/A Priority: Normal
NCT ID: NCT00494767 Org: User:
Start: 09/29/06 End: 06/07/07 Due: 06/07/08

WEUKBRE5555: IMI PROTECT(Work Package 2): Liver Injury & Antibiotics

Phase: N/A Priority: Normal
NCT ID: NCT01587768 Org: User:
Start: 11/30/11 End: 07/31/14 Due: 07/31/15

A Study to Assess the Systemic Exposure of FLIXOTIDE™ (Fluticasone Propionate) and SERETIDE™ (Fluticasone Propionate and Salmeterol) Given With VENTOLIN™ Mini-Spacer Compared to the Aerochamber Plus Spacer

Phase: N/A Priority: Normal
NCT ID: NCT02045953 Org: User:
Start: 01/29/14 End: 03/13/14 Due: 03/13/15

Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT01431976 Org: User:
Start: 09/30/11 End: 11/30/15 Due: 11/30/16

Study of a Booster Dose of Hib-MenC Conjugate Vaccine vs Infanrix Hexa When Given to 14 Month Old Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00323050 Org: User:
Start: 11/30/04 End: 03/31/05 Due: 03/31/06

Pilot Study of Patient's Adherence to TYKERB™/TYVERB™ + Capecitabine in Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01462604 Org: User:
Start: 11/23/11 End: 01/24/13 Due: 01/24/14

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK2269557 Administered Via the ELLIPTA Dry Powder Inhaler to Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02691325 Org: User:
Start: 03/14/16 End: 06/05/16 Due: 06/05/17

Evaluate 4 Different Formulations of Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs

Phase: N/A Priority: Normal
NCT ID: NCT00126945 Org: User:
Start: 08/31/05 End: 10/31/05 Due: 10/31/06

Study to Assess the Pharmacokinetics and Pharmacodynamics of GSK461364 in Subjects With Non-Hodgkins Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00536835 Org: User:
Start: 08/16/07 End: 09/29/09 Due: 09/29/10

AVODART® Alopecia Post-marketing Surveillance (PMS)

Phase: N/A Priority: Normal
NCT ID: NCT01004809 Org: User:
Start: 04/29/10 End: 12/21/12 Due: 12/21/13

Eltrombopag Taste Testing in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00487968 Org: User:
Start: 05/31/07 End: - Due: -

Clinical Endpoint Trial Investigating Once Daily and Bronchodilator Dosing

Phase: N/A Priority: Normal
NCT ID: NCT00549744 Org: User:
Start: 11/16/07 End: 08/27/08 Due: 08/27/09

A Study To Evaluate Formulations And Food Effect On GSK364735 In Healthy Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT00386347 Org: User:
Start: 10/31/06 End: - Due: -